Of particular importance, the S1P-mimicking agent fingolimod (FTY720), an immunosuppressive drug against MS, is phosphorylated by SphK2 in vivo (Paugh et al., 2003). The gene discussed is SPHK2; the disease is myeloid sarcoma.